Effect of Ultrasonographic Guided Insulin Injection With Dexamethasone and Local Anesthetic Mixture in Diabetic Patients With Mild to Moderate Carpal Tunnel .

What Was Tested

The trial (not phased) is built around Insulin (regular human) for carpal tunnel.

It had two arms (groups): Control group (no intervention) and Insulin group (active comparator).

Dexmehtasone and local anesthetics in carpal tunnel syndrome.

Insulin added to dexamehtasone and local anesthetics.

The registry classes the interventions as drug.

Who Took Part

The registry lists 250 planned participants were the target.

It was open to people of any sex aged from 20 years up to 70 years.

Healthy volunteers were not accepted; participants needed the condition being studied.

The full record lists 0 inclusion and 1 exclusion criteria; among the exclusions: refusal to participate.

How the Study Was Run

It was run as a randomized, parallel-group and double-blind study.

Because people in this Insulin (regular human) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

The Insulin (regular human) group and the comparison group ran side by side rather than switching.

Neither the carpal tunnel participants nor the staff measuring them knew who was on Insulin (regular human), so expectations could not easily colour the readings.

Those kept unaware of assignments: participant and investigator.

It started in 2021-03-01 with completion listed for 2021-05-05.

Its stated primary purpose is treatment.

What Was Measured

The main thing measured (primary outcome): pain neuropathy (time frame: 12 weeks).

What This Means in Plain Language

Put simply, this is a not phased, randomized trial of Insulin (regular human) in 250 people with carpal tunnel.

Its status is unknown; no results are posted to the registry yet, so nothing here describes outcomes.

More context: the Insulin (regular human) compound page, Carpal tunnel research.